0001140361-24-035394.txt : 20240801
0001140361-24-035394.hdr.sgml : 20240801
20240801180927
ACCESSION NUMBER: 0001140361-24-035394
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240730
FILED AS OF DATE: 20240801
DATE AS OF CHANGE: 20240801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Backus William A.
CENTRAL INDEX KEY: 0001530884
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13648
FILM NUMBER: 241168211
MAIL ADDRESS:
STREET 1: 52 SUNRISE PARK ROAD
CITY: NEW HAMPTON
STATE: NY
ZIP: 10958
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BALCHEM CORP
CENTRAL INDEX KEY: 0000009326
STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 132578432
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 PARAGON DRIVE
CITY: MONTVALE
STATE: NJ
ZIP: 07645
BUSINESS PHONE: (845) 326-5600
MAIL ADDRESS:
STREET 1: 5 PARAGON DRIVE
CITY: MONTVALE
STATE: NJ
ZIP: 07645
4
1
form4.xml
FORM 4
X0508
4
2024-07-30
0000009326
BALCHEM CORP
BCPC
0001530884
Backus William A.
C/O BALCHEM CORPORATION
5 PARAGON DRIVE
MONTVALE
NJ
07645
true
VP & Chief Accounting Officer
false
Common Stock
2024-07-30
4
M
0
3900
84.09
A
8888
D
Common Stock
2024-07-30
4
S
0
3570
179.247
D
5318
D
Common Stock
2024-07-30
4
S
0
330
180.4656
D
4988
D
Common Stock
2024-07-30
4
S
0
904
177.0955
D
132
I
401(k) Plan
Stock Options (right to buy)
84.09
2024-07-30
4
M
0
3900
0
D
2029-02-13
Common Stock
3900
0
D
Exercise of fully vested non-qualified stock options.
This transaction was executed in multiple sales ranging from $179.0200 to $179.9700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
This transaction was executed in multiple sales ranging from $180.3050 to $180.5900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
Intra-plan transfer from the Balchem Common Stock Fund to another fund within the Balchem Corporation 401(k) plan.
Reflects shares previously acquired under the Balchem Corporation 401(k) plan.
Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.
/s/ Travis Larsen, Attorney in Fact
for William A Backus
2024-08-01